IDEX Biometrics (IDEX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
24 Aug, 2026Executive summary
Active pilot base tripled to 23 as of August 2026, up from 7 in May, with 11 live and 12 signed pilots; one Pay pilot converted to a full order by an Indian bank.
Four purchase orders secured in Q2 across Access and Pay segments; channel partner network expanded from 9 to 25, broadening reach and supporting larger projects.
Achieved FIDO Authenticator Certification Level 2 and launched the world’s first certified Visa FIDO2 biometric card, enhancing access to high-security customers.
Focus on cybersecurity, post-quantum readiness, and seamless mobile integration, with two new products in stealth mode.
Commercial focus shifted to converting pilots into firm orders, with significant revenue growth expected from Q3 2026.
Financial highlights
Q2 2026 revenue reached NOK 1.6 million, up from NOK 0.9 million in Q1 2026 and NOK 0.8 million in Q2 2025.
Gross margin at 19% in Q2 2026, up from 15% in Q1 2026 but down from 28% in Q2 2025; new POs expected to drive margins higher.
Adjusted EBITDA was negative NOK 20.2 million in Q2 2026, improving year-over-year.
Net result for Q2 2026 was negative NOK 9.0 million, including a NOK 13.2 million non-cash gain from derecognition of the Heights loan.
Cash and cash equivalents at period end were NOK 28.5 million, with no interest-bearing debt after equity raise and debt repayment.
Outlook and guidance
Material step-up in order intake and revenue expected in H2 2026 as pilots convert and backlog is delivered.
Q3 2026 revenue expected to exceed NOK 8.5 million, with NOK 4.5 million already shipped.
Operating costs to rise in Q3 due to increased sales and marketing efforts.
Significant scale expected from channel partners, with new pilots and direct orders bypassing pilot phase.
Public sector tenders in Norway for IAM solutions set for H2, with potential for large-scale wins.
Latest events from IDEX Biometrics
- Record backlog, improved margins, and accelerated commercial activity signal a strong 2026 outlook.IDEX
Q1 2026 - Certified biometric products launched, costs cut, but liquidity and sales targets remain challenges.IDEX
Q4 2025 - Q3 2025 saw a 60% OPEX drop, new biometric card launches, and ongoing liquidity risk.IDEX
Q3 2025 - Biometric access cards drive growth, aiming for breakeven in Q4 2025.IDEX
Company Presentation - Cost reductions and new funding support ongoing operations amid continued losses and product launches.IDEX
Q2 2025 - Q3 saw cost cuts, capital raised, and major biometric card approvals amid market risks.IDEX
Q3 2024 - Q2 revenue was $0.4M, margin 40%, costs down, but liquidity and growth risks remain.IDEX
Q2 2024 - Q1 2025 saw a $4.1M net loss, liquidity strain, and urgent need for new funding.IDEX
Q1 2025 - No Q4 revenue, net loss, and liquidity risk, but certifications and launches support future growth.IDEX
Q4 2024